Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 13/20 | 1.00 |
| ▸ | EGFR | P00533 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | TLR4 | O00206 | 1/20 | 0.50 |
| ▸ | TLR2 | O60603 | 1/20 | 0.50 |
| ▸ | VCP | P55072 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL794129 | 1.00 | FBP1 (1.00) | FBP1EGFRMAOAMAOBALDH1A1 | |
| SCHEMBL4905572 | 0.90 | FBP1 (0.81) | FBP1EGFRMAOAMAOBALDH1A1 | |
| SCHEMBL4905578 | 0.90 | FBP1 (0.81) | FBP1EGFRMAOAMAOBALDH1A1 | |
| SCHEMBL6910818 | 0.83 | FBP1 (0.78) | FBP1EGFRALDH1A1LMNAMAPT | |
| SCHEMBL6910815 | 0.83 | FBP1 (0.78) | FBP1EGFRALDH1A1LMNAMAPT | |
| SCHEMBL8638551 | 0.81 | FBP1 (0.68) | FBP1EGFRALDH1A1LMNAMAPT | |
| SCHEMBL8638549 | 0.81 | FBP1 (0.68) | FBP1EGFRALDH1A1LMNAMAPT | |
| SCHEMBL7412199 | 0.81 | FBP1 (0.70) | FBP1EGFRMAOAMAOBVCP | |
| SCHEMBL3862500 | 0.79 | FBP1 (1.00) | FBP1MAOAMAOBTLR4TLR2 | |
| SCHEMBL30592090 | 0.79 | FBP1 (1.00) | FBP1MAOAMAOBTLR4TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7132219-B2 | Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition | BREWER SCIENCE INC. (US) | 2006-11-07 | — | — | US | claimed |
| US-20030219541-A1 | Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition | BREWER SCIENCE, INC. | 2003-11-27 | — | — | US | claimed |
| US-20030064608-A1 | Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition | SABNIS RAM W (US) | 2003-04-03 | — | — | US | claimed |
| US-20030054117-A1 | Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition | BREWER SCIENCE, INC. | 2003-03-20 | — | — | US | claimed |
| CN-117362140-A | Synthesis method of cyclohexyl substituted styrenes compound | 浙江工业大学 | 2024-01-09 | — | — | CN | disclosed |
| EP-3630721-B1 | HERBICIDAL AMIDES | FMC CORP (US) | 2022-01-05 | — | — | EP | disclosed |
| EP-3630721-A1 | HERBICIDAL AMIDES | FMC Corporation (US) | 2020-04-08 | — | — | EP | disclosed |
| WO-2018222646-A1 | HERBICIDAL AMIDES | FMC CORPORATION (US) | 2018-12-06 | — | — | WO | disclosed |
| CN-103497082-B | A kind of method preparing beta-nitrostyrene and derivative thereof | TAIZHOU UNIVERSITY (CN) | 2015-12-02 | — | — | CN | disclosed |
| US-8946260-B2 | 17α-hydroxylase/C17,20-lyase inhibitors | NOVARTIS AG (CH) | 2015-02-03 | — | — | US | disclosed |
| US-8946260-B2 | 17α-hydroxylase/C17,20-lyase inhibitors | NOVARTIS AG (CH) | 2015-02-03 | — | — | US | disclosed |
| US-8946260-B2 | 17α-hydroxylase/C17,20-lyase inhibitors | NOVARTIS AG (CH) | 2015-02-03 | — | — | US | disclosed |
| US-20040068074-A1 | Production process for silsesquioxane derivative having functional group and silsesquioxane derivative | JNC CORPORATION (JP) | 2004-04-08 | — | — | US | disclosed |
| US-20030219541-A1 | Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition | BREWER SCIENCE, INC. | 2003-11-27 | — | — | US | disclosed |
| EP-0923581-B1 | 4-SUBSTITUTED BETA-CARBOLINES AS IMMUNOMODULATORS | BOEHRINGER INGELHEIM PHARMA (US) | 2003-05-21 | — | — | EP | disclosed |
| US-20030064608-A1 | Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition | SABNIS RAM W (US) | 2003-04-03 | — | — | US | disclosed |
| US-20030054117-A1 | Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition | BREWER SCIENCE, INC. | 2003-03-20 | — | — | US | disclosed |
| US-6093723-A | AN IMMUNOMODULATOR FOR TREATING AND PREVENTING IMMUNE DISORDERS, INCLUDING AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE, ORGAN TRANSPLANT REJECTION AND OTHER DISORDERS ASSOCIATED WITH IL-2 MEDIATED IMMUNE RESPONSE | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2000-07-25 | — | — | US | disclosed |
| EP-0923581-A1 | 4-SUBSTITUTED BETA-CARBOLINES AS IMMUNOMODULATORS | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 1999-06-23 | — | — | EP | disclosed |
| WO-1998006719-A1 | 4-SUBSTITUTED BETA-CARBOLINES AS IMMUNOMODULATORS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1998-02-19 | — | — | WO | disclosed |